SYBLEU Inc
company.status.inactiveCIK 1818674fmd_1QDYTBERCKTJK42FNCRGQR8JG9Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2019 to Dec 31, 2023, 15 periods
| Line item | FY2021 | FY2022 | FY2023 |
|---|---|---|---|
| Total revenues | 0 | 0 | 0 |
| Net interest income | 0 | (0) | (0) |
| Research and development | 0 | 0 | 0 |
| Operating income | (0) | (0) | (0) |
| Other non-operating income (expense) | 0 | (0) | (0) |
| Income before taxes | (0) | (0) | (0) |
| Income tax expense | 0 | 0 | – |
| Net income from continuing operations | (0) | (0) | – |
| Net income | (0) | (0) | (0) |
| Net income to common shareholders | (0) | (0) | (0) |